PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $46,000 | -6.1% | 75,288 | 0.0% | 0.00% | – |
| Q1 2017 | $49,000 | +157.9% | 75,288 | +24.2% | 0.00% | – |
| Q4 2016 | $19,000 | -26.9% | 60,640 | 0.0% | 0.00% | – |
| Q3 2016 | $26,000 | +18.2% | 60,640 | -0.9% | 0.00% | – |
| Q2 2016 | $22,000 | -21.4% | 61,193 | -6.8% | 0.00% | – |
| Q1 2016 | $28,000 | -61.1% | 65,639 | +5.8% | 0.00% | – |
| Q4 2015 | $72,000 | +50.0% | 62,046 | +32.2% | 0.00% | – |
| Q3 2015 | $48,000 | -27.3% | 46,917 | -5.9% | 0.00% | – |
| Q2 2015 | $66,000 | +3.1% | 49,876 | +4.7% | 0.00% | – |
| Q1 2015 | $64,000 | +3.2% | 47,644 | +7.5% | 0.00% | – |
| Q4 2014 | $62,000 | +29.2% | 44,337 | +25.5% | 0.00% | – |
| Q3 2014 | $48,000 | -70.0% | 35,336 | -58.5% | 0.00% | – |
| Q2 2014 | $160,000 | -11.6% | 85,178 | -10.9% | 0.00% | -100.0% |
| Q1 2014 | $181,000 | +74.0% | 95,650 | +27.7% | 0.00% | – |
| Q4 2013 | $104,000 | +15.6% | 74,873 | +17.2% | 0.00% | – |
| Q3 2013 | $90,000 | +26.8% | 63,859 | +15.3% | 0.00% | – |
| Q2 2013 | $71,000 | – | 55,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |